{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:27:49Z","timestamp":1790954869614,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with chronic kidney disease (CKD) have a high risk of left ventricular hypertrophy (LVH). Fibroblast growth factor 23 (FGF23) and indoxyl sulfate (IS) are associated with LVH in patients with CKD, but the interactions between these molecules remain unknown. We investigated whether IS contributes to LVH associated with FGF23 in cultured cardiomyocytes and CKD mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>In cultured rat cardiac myoblast H9c2 cells incubated with IS, mRNA levels of the LVH markers atrial natriuretic factor, brain natriuretic peptide, and \u03b2-myosin heavy chain were significantly upregulated. Levels of mRNA of the polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), which regulates FGF23 O-glycosylation, and FGF23 were also upregulated in H9c2 cells. Intact FGF23 protein expression and fibroblast growth factor receptor 4 (FGFR4) phosphorylation were increased in cell lysates by IS administration. In C57BL\/6J mice with heminephrectomy, IS promoted LVH, whereas the inhibition of FGFR4 significantly reduced heart weight and left ventricular wall thickness in IS-treated groups. While there was no significant difference in serum FGF23 concentrations, cardiac FGF23 protein expression was markedly increased in IS-injected mice. GALNT3, hypoxia-inducible factor 1 alpha, and FGF23 protein expression was induced in H9c2 cells by IS treatment and suppressed by the inhibition of Aryl hydrocarbon receptor which is the receptor for IS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that IS increases FGF23 protein expression via an increase in GALNT3 and hypoxia-inducible factor 1 alpha expression, and activates FGF23-FGFR4 signaling in cardiomyocytes, leading to LVH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.990422","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T04:31:05Z","timestamp":1676953865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway"],"prefix":"10.3389","volume":"10","author":[{"given":"Hiroshi","family":"Kishimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tokumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","article-title":"Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study.","volume":"68","author":"Ninomiya","year":"2005","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States.","volume":"59","author":"Collins","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1097\/01.asn.0000019641.41496.1e","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the choice study.","volume":"13","author":"Longenecker","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease.","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to moderate kidney disease (MMKD) study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","article-title":"Relationship between circulating FGF23 and total body atherosclerosis in the community.","volume":"24","author":"Mirza","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease.","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1002\/jps.22592","article-title":"Update on the pharmacokinetics and redox properties of protein-bound uremic toxins.","volume":"100","author":"Watanabe","year":"2011","journal-title":"J Pharm Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy.","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats.","volume":"32","author":"Leifheit-Nestler","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3390\/ijms21062186","article-title":"Soluble Alpha-klotho alleviates cardiac fibrosis without altering cardiomyocytes renewal.","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability.","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1189\/jlb.0112023","article-title":"Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.","volume":"93","author":"Ito","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.3390\/toxins7083155","article-title":"Increased proinflammatory cytokine production and decreased cholesterol efflux due to downregulation of ABCG1 in macrophages exposed to indoxyl sulfate.","volume":"7","author":"Matsuo","year":"2015","journal-title":"Toxins."},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","article-title":"Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch signaling.","volume":"139","author":"Nakano","year":"2019","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41589-019-0444-x","article-title":"Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.","volume":"16","author":"de Las Rivas","year":"2020","journal-title":"Nat Chem Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/toxsci\/kfu043","article-title":"Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells.","volume":"139","author":"Kido","year":"2014","journal-title":"Toxicol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.14800\/ics.279","article-title":"Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100\/RAGE and FGF23.","volume":"1","author":"Yan","year":"2014","journal-title":"Inflamm Cell Signal."},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00223-021-00823-6","article-title":"Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23.","volume":"109","author":"Ito","year":"2021","journal-title":"Calcif Tissue Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/cells8010031","article-title":"Fibroblast growth factor receptor 4 targeting in cancer: new insights into mechanisms and therapeutic strategies.","volume":"8","author":"Lang","year":"2019","journal-title":"Cells."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2016.00030","article-title":"Roles of FGFs as paracrine or endocrine signals in liver development, health, and disease.","volume":"13","author":"Ito","year":"2016","journal-title":"Front Cell Dev Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ndt\/gfaa227","article-title":"Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.","volume":"3","author":"Sch\u00f6n","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin.","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.3390\/ijms20184634","article-title":"FGF23-mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis.","volume":"20","author":"B\u00f6ckmann","year":"2019","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.990422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T04:31:10Z","timestamp":1676953870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.990422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2023.990422"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.990422","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"article-number":"990422"}}